Key facts
- This page summarizes Robert Noreck's Form 4 filing for BRIGHTCOVE INC.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Mar 2023, 16:15.
Robert Noreck - 20 Mar 2023 Form 4 Insider Report for BRIGHTCOVE INC
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 20 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2023, 16:15:14 UTC
- Prior SEC filing
- 12 Dec 2022
- Next SEC filing
- 12 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Keenan, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Noreck filed Form 4 for BRIGHTCOVE INC on 21 Mar 2023.
Change
- Previous filing in this sequence was filed on 12 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BCOV
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +70,203
- Change %
- +40%
- Price
- $0.000000
- Shares after
- 246,571
- Date
- 20 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BCOV
transaction
Derivative
Premium-Priced Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +171,103
- Change %
- Price
- $0.000000
- Shares after
- 171,103
- Date
- 20 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 171,103
- Exercise price
- $7.00
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These shares were acquired pursuant to a restricted stock unit award under the Brightcove Inc. 2021 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Brightcove Inc. common stock. The restricted stock units vest in three equal annual installments beginning on March 10, 2024.
Footnote F2
This premium-priced stock option has an exercise price of $7.00 and will therefore only have value if the Issuer's stock price appreciates by at least 59% from the closing stock price on the date of grant.
Footnote F3
This premium-priced stock option vests in three equal annual installments beginning on March 10, 2024.